TAKING paracetamol during pregnancy does not increase a child's risk of autism, ADHD, or intellectual disabilities, according to evidence reviewed by an international team of researchers.
Evidence from 43 previous studies, including pooled data re-analysed from 17 of them, found no link, according to research published in The Lancet Obstetrics, Gynaecology, & Women's Health journal.
The absence of a connection between paracetamol and autism spectrum disorder, ADHD, and intellectual disabilities held firm when the researchers selected only the most robust studies with at least five years of follow-up.
These finds back up a range of bodies from the pharmaceutical industry which came together in Sep to hit out against claims to the contrary made by President of the United States, Donald Trump (PD 23 Sep).
"In Australia, the TGA has reiterated that paracetamol remains Pregnancy Category A in Australia, meaning it is considered safe for use in pregnancy," a Pharmacy Guild of Australia spokesperson told Pharmacy Daily at the time.
"All healthcare professionals, including community pharmacists, should stay abreast of the latest information, guidance and advice from the TGA."
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jan 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jan 26
